Deerfield Management Company »

Odyssey Therapeutics shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Odyssey Therapeutics shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Odyssey Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Odyssey Therapeutics held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Odyssey Therapeutics by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $20M 1.0M 18.71

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
Centene Corporation (CNC)
Revolution Medicines Note 0.500% 5/0 (Principal)
United Therapeutics Corporation (UTHR)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Cogent Biosciences (COGT)
Genmab A/s Sponsored Ads (GMAB)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Odyssey Therapeutics

FMR
Sr One Capital Management
Lightspeed Management Company
OrbiMed Advisors
Sanofi
Deerfield Management Company
Sands Capital Ventures
Hillhouse Capital Advisors
General Catalyst Group Management
Affinity Asset Advisors
Adage Capital Partners GP
Vanguard Capital Management
Foresite Capital Management V
Vivo Capital
EcoR1 Capital

View all funds holding Odyssey Therapeutics